Skip to main content

Table 1 The baseline information

From: Postoperative intermittent pneumatic compression for preventing venous thromboembolism in Chinese lung cancer patients: a randomized clinical trial

 

Control group

(N = 217)

Experimental group

(N = 219)

P value

Gender: male

86 (39.6%)

75 (34.2%)

0.244

Smoking status: yes

57 (26.3%)

53 (24.2%)

0.619

Pathological type: adenocarcinoma

200 (92.2%)

198 (90.4%)

0.516

Lung cancer stage: early

192(88.5%)

201(91.8%)

0.320

Age (years)

53 [48, 57]

52 [47, 57]

0.078

BMI (kg/m2)

23.5 [21.6, 25.7]

23.4 [21.4, 25.0]

0.285

D-dimera(mg/L)

0.18 [0.12, 0.27]

0.17 [0.12, 0.26]

0.740

PT a (s)

10.3 [10.0, 10.7]

10.3 [9.9, 10.7]

0.331

APTT a(s)

26.8 [25.5, 28.1]

26.6 [25.4, 27.9]

0.250

FIBa (g/L)

2.62 [2.27, 3.01]

2.59 [2.33, 3.00]

0.792

TTa(s)

17.9 [17.4, 18.5]

18.0 [17.4, 18.5]

0.737

PLTa(10^9/L)

200 [167, 237]

202 [170, 246]

0.456

Perimeter a (cm)

35.65 [34.10, 37.40]

35.58 [33.90, 37.21]

0.754

CTVR(%)

24.0 [20.0, 27.6]

24.0 [21.1, 27.7]

0.279

Surgical typeb: Lobectomy

169 (77.9%)

180 (82.2%)

0.229

Wedge Resection

39 (18.0%)

27 (12.3%)

 

Segmentectomy

9 (4.15%)

12 (5.48%)

 

Lymph node dissectionb

176(81.1%)

189(86.3%)

0.142

Pleural adhesionsb

50 (23.0%)

50 (22.8%)

1

Caprine c(points)

7 [7, 8]

7 [7, 7]

0.257

  1. Values were presented as n (%) or median [IQR]. a indicated preoperative results; b indicated the intraoperative results; c indicated postoperative results
  2. Abbreviations: BMI Body mass index, PT Prothrombin time, APTT Activated partial thromboplastin time, FIB Fibrinogen, TT Thrombin time, PLT Platelet, CTVR Tube diameter/internal venous internal diameter, CVC Central venous catheter